[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 66, "title": "CEO, CFO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 47, "title": "COO & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6803, "open": 0.68, "dayLow": 0.68, "dayHigh": 0.7212, "regularMarketPreviousClose": 0.6803, "regularMarketOpen": 0.68, "regularMarketDayLow": 0.68, "regularMarketDayHigh": 0.7212, "payoutRatio": 0.0, "beta": 1.342, "forwardPE": -0.07639254, "volume": 77198, "regularMarketVolume": 77198, "averageVolume": 388115, "averageVolume10days": 167960, "averageDailyVolume10Day": 167960, "bid": 0.4918, "ask": 0.897, "bidSize": 2, "askSize": 2, "marketCap": 3480469, "fiftyTwoWeekLow": 0.6, "fiftyTwoWeekHigh": 5.15, "fiftyDayAverage": 0.7268, "twoHundredDayAverage": 1.8917, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3840873, "profitMargins": 0.0, "floatShares": 4301790, "sharesOutstanding": 4795650, "sharesShort": 175087, "sharesShortPriorMonth": 53241, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.035, "heldPercentInsiders": 0.00464, "heldPercentInstitutions": 0.05434, "shortRatio": 0.51, "shortPercentOfFloat": 0.0367, "impliedSharesOutstanding": 4995650, "bookValue": 1.212, "priceToBook": 0.57483494, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -13141000, "trailingEps": -6.07, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": 0.285, "52WeekChange": -0.8481562, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 0.6967, "targetHighPrice": 16.0, "targetLowPrice": 2.0, "targetMeanPrice": 10.66667, "targetMedianPrice": 14.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 7242000, "totalCashPerShare": 1.51, "ebitda": -13493000, "totalDebt": 58000, "quickRatio": 2.636, "currentRatio": 2.84, "debtToEquity": 1.088, "returnOnAssets": -0.80942, "returnOnEquity": -1.70718, "freeCashflow": -7367500, "operatingCashflow": -11346000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1749249814, "regularMarketTime": 1749240000, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Palisade Bio, Inc.", "shortName": "Palisade Bio, Inc.", "fiftyDayAverageChange": -0.030100048, "fiftyDayAverageChangePercent": -0.041414484, "twoHundredDayAverageChange": -1.195, "twoHundredDayAverageChangePercent": -0.63170695, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 2.4107, "regularMarketPrice": 0.6967, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": 2.82762, "postMarketPrice": 0.7164, "postMarketChange": 0.0197001, "regularMarketChange": 0.0164, "regularMarketDayRange": "0.68 - 0.7212", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 388115, "fiftyTwoWeekLowChange": 0.09669995, "fiftyTwoWeekLowChangePercent": 0.16116658, "fiftyTwoWeekRange": "0.6 - 5.15", "fiftyTwoWeekHighChange": -4.4533, "fiftyTwoWeekHighChangePercent": -0.86471844, "fiftyTwoWeekChangePercent": -84.81562, "dividendDate": 1563408000, "earningsTimestamp": 1747080000, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.07, "epsForward": -9.12, "epsCurrentYear": -1.45667, "priceEpsCurrentYear": -0.47828263, "marketState": "CLOSED", "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]